1 not yet recruiting, 1 recruiting, 1 unknown. 1 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Sickle-Cell Disease with Crisis: new trials by email Literature Review of Sickle-Cell Disease with Crisis trials Research Report on Sickle-Cell Disease with Crisis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Analgesic Effect of Parecoxib Versus Morphine in SCD Patients Presenting to the Emergency Department Parecoxib, Morphine - Sickle-Cell Disease with Crisis | Phase 3 | Not yet recruiting | Oman Medical Speciality Board | 226 | 2026-05-01 | 2025-03-20 |
| Investigation Into the Use of BAH243 Lentiviral Vector for Gene Therapy in Treating Sickle Cell Disease Drug Product is administered by IV infusion following myeloablative conditioning with busulfan - Sickle Cell Disease, Sickle-Cell Disease With Crisis | Phase 1 / Phase 2 | Recruiting | Essen Biotech | 85 | 2024-08-01 | 2024-11-05 |
| DSUVIA in Patients With SCD VOC Present in the ED sublingual sufentanil - Sickle-Cell Disease With Crisis | Unknown | Jason Wilson | 100 | 2022-03-30 | 2022-05-24 |
Vaso-Occlusive Crises (3) · Anemia, Sickle Cell (2)
Anemia (3) · Anemia, Hemolytic (3) · Anemia, Hemolytic, Congenital (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Genetic Diseases, Inborn (3) · Hematologic Diseases (3) · Hemic and Lymphatic Diseases (3) · Hemoglobinopathies (3) · Anemia, Sickle Cell (1)
Busulfan (1) · Morphine (1) · parecoxib (1)
Essen Biotech (1) · Jason Wilson (1) · Oman Medical Speciality Board (1)
China (1) · United States (1)
Jason Wilson, MD (1) · Muzna Al Sawafi, MD (1)